{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T12:44:18Z","timestamp":1648903458511},"reference-count":17,"publisher":"Japan Society for Clinical Immunology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. J. Clin. Immunol.","Jpn.J.clin.Immun"],"published-print":{"date-parts":[[2014]]},"DOI":"10.2177\/jsci.37.48","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T23:11:57Z","timestamp":1393974717000},"page":"48-54","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of the relationship between polymyalgia rheumatica and matrix metalloproteinase-3 levels during the first medical examination and during treatment"],"prefix":"10.2177","volume":"37","author":[{"given":"Kouhei","family":"MIYAKE","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Chugoku central hospital, Mutual Aid Association of Public School Teachers"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"KATSUYAMA","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Clinical Science, Okayama University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1"},{"key":"2","unstructured":"2) Mori, S., et al.: Clinical characteristics of polymyalgia rheumatica in Japanese patients: evidence of synovitis and extracapsular inflammatory changes by fat suppression magnetic resonance imaging. <i>Mod Rheumatol<\/i>. <b>17<\/b>: 369-375, 2007."},{"key":"3","unstructured":"3) Yamashita, H., et al.: Whole-body fluorodeoxyglucose positron emission tomography\/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis. <i>Mod Rheumatol<\/i>. <b>22<\/b>: 705-711, 2012."},{"key":"4","unstructured":"4) Dasgupta, B., et al.: 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. <i>Arthritis Rheum<\/i>. <b>64<\/b>: 943-954, 2012."},{"key":"5","unstructured":"5) Birkedal-Hansen, H., et al.: Matrix metalloproteinases: a review. <i>Crit Rev Oral Biol Med<\/i>. <b>4<\/b>: 197-250, 1993."},{"key":"6","unstructured":"6) Vincenti, M.P., et al.: Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? <i>Arthritis Rheum<\/i>. <b>37<\/b>: 1115-1126, 1994."},{"key":"7","unstructured":"7) Cawston, T.: Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases. <i>Mol Med Today<\/i>. <b>4<\/b>: 130-137, 1998."},{"key":"8","unstructured":"8) Taylor, D.J., et al.: Increased serum proMMP-3 in inflammatory arthritides: a potential indicator of synovial inflammatory monokine activity. <i>Ann Rheum Dis<\/i>. <b>53<\/b>: 768-772, 1994."},{"key":"9","unstructured":"9) Ishiguro, N., et al.: Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis. <i>J Rheumatol<\/i>. <b>23<\/b>: 1599-1604, 1996."},{"key":"10","unstructured":"10) Yamanaka, H., et al.: Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. <i>Arthritis Rheum<\/i>. <b>43<\/b>: 852-858, 2000."},{"key":"11","unstructured":"11) Shinozaki, M., et al.: Elevation of serum matrix metalloproteinase-3 as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA. <i>Mod Rheumatol<\/i>. <b>17<\/b>: 403-408, 2007."},{"key":"12","unstructured":"12) Ribbens, C., et al.: Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. <i>Ann Rheum Dis<\/i>. <b>61<\/b>: 161-166, 2002."},{"key":"13","unstructured":"13) Yanai, H., et al.: Clinical, radiological, and biochemical characteristics in patients with diseases mimicking polymyalgia rheumatica. <i>Clin Interv Aging<\/i>. <b>4<\/b>: 391-395, 2009."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kanda, Y.: Investigation of the freely-available easy-to-use software \u201cEZR\u201d (Easy R) for medical statistics. <i>Bone Marrow Transplant<\/i>. <b>48<\/b>: 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"15","unstructured":"15) Caporali, R., et al.: Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study. <i>Ann Rheum Dis<\/i>. <b>60<\/b>: 1021-1024, 2001."},{"key":"16"},{"key":"17","unstructured":"17) Sharif, M., et al.: Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis. <i>Arthritis Rheum<\/i>. <b>41<\/b>: 1203-1209, 1998."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/37\/1\/37_48\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T04:56:40Z","timestamp":1621486600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/37\/1\/37_48\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.37.48","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}